City of Hope Is Enrolling Patients in First of Its Kind Clinical Trial for Brain Tumor Patients
The trial, which received a $4.1 million in grants from the National Institutes of Health and Gateway for Cancer Research, combines City of Hope’s unique CAR T cell therapy with immune checkpoint inhibitors DUARTE, Calif.–(BUSINESS WIRE)–#CityofHope–City of Hope has opened a first-in-human clinical trial for patients with recurrent glioblastoma – the trial is the first … [Read more…]
